SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥142.40-CN¥0.49 (-0.34%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 17.97% below the high.
Loading market information…
SHZ · 002393.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:15 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Tianjin Lisheng Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.18% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Tianjin Lisheng Pharmaceutical Co.,Ltd.’s forward annual dividend is CN¥1.20 per share, paid semi-annual. The forward yield is 9.53% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Tianjin Lisheng Pharmaceutical Co.,Ltd.’s next earnings report is currently expected on Mar 19, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Tianjin Lisheng Pharmaceutical Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Tianjin Lisheng Pharmaceutical Co.,Ltd. specializes in the manufacturing and distribution of chemical pharmaceutical products. Their extensive catalog features a variety of finished dosage forms, including tablets, hard capsules, dripping pills, freeze-dried powder injections, and water injections, alongside bulk medicines. The company also provides pharmaceutical intermediates, diagnostic reagents, biochemical reagents, and plastic bottles. Headquartered in Tianjin, China, the firm extends its reach through product exports. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:31 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥312.38M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥142.40-CN¥0.49 (-0.34%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 17.97% below the high.
CN¥48.55-CN¥0.07 (-0.14%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.2% below the high.
CN¥21.68+CN¥0.48 (+2.26%)
Jiangsu Nhwa Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.64% below the high.
CN¥9.21+CN¥0.13 (+1.43%)
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.37% below the high.
CN¥8.90+CN¥0.04 (+0.45%)
Zhejiang Xianju Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 11.34% below the high.
CN¥2.93+CN¥0.05 (+1.74%)
Harbin Gloria Pharmaceuticals Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.55% below the high.
CN¥6.91+CN¥0.13 (+1.92%)
Jinghua Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.95% below the high.
$5.41+$0.29 (+5.66%)
Journey Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 43.41% below the high.
